Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 21.1% in November

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 766,100 shares, a growth of 21.1% from the November 15th total of 632,500 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Ascentage Pharma Group International Stock Performance

ASPHF stock remained flat at $6.45 during midday trading on Friday. Ascentage Pharma Group International has a 1-year low of $6.45 and a 1-year high of $6.45. The business has a fifty day moving average price of $5.77 and a two-hundred day moving average price of $3.77.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.